AMANDA CHAGOLLA: Open Payments
NPI 1184237885 · TAYLOR, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,318 in 62 payments from 14 companies in 2025. Trend: 2023 $1,769 · 2024 $3,302 · 2025 $1,318
Food & beverage: $1,318
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 7 | $331 |
| ABBVIE INC. | 12 | $252 |
| Collegium Pharmaceutical, Inc. | 14 | $219 |
| Supernus Pharmaceuticals, Inc. | 9 | $141 |
| Corium, LLC | 8 | $101 |
| Teva Pharmaceuticals USA, Inc. | 1 | $93 |
| Vanda Pharmaceuticals Inc. | 3 | $54 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $32 |
| Sage Therapeutics, LLC | 1 | $20 |
| Alkermes, Inc. | 1 | $16 |
Products named: Auvelity, VRAYLAR, Jornay PM, Qelbree, Azstarys, AUSTEDO XR, FANAPT, CAPLYTA.
Industry payments across MI — which companies pay providers there.
